AXSM

Axsome Therapeutics Inc
61.96
-0.05 (-0.08%)
Company Name Stock Ticker Symbol Market Type
Axsome Therapeutics Inc AXSM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.05 -0.08% 61.96 19:43:10
Open Price Low Price High Price Close Price Prev Close
61.40 59.74 62.5821 61.96 62.01
more quote information »

Recent News

Date Time Source Heading
3/14/202309:30PRNUSSHAREHOLDER ALERT: Axsome Therapeutics, Inc. (AXSM) Officers..
3/13/202306:04EDGARCurrent Report Filing (8-k)
3/10/202315:44EDGARCurrent Report Filing (8-k)
3/06/202318:17EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202318:16EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202318:15EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202318:15EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202318:14EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202318:13EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202318:13EDGARStatement of Changes in Beneficial Ownership (4)
3/01/202307:00GLOBEAxsome Therapeutics to Present at Cowen’s 43rd Annual Health..
2/27/202307:06EDGARCurrent Report Filing (8-k)
2/27/202307:00GLOBEAxsome Therapeutics Reports Fourth Quarter and Full Year..
2/22/202307:00GLOBEAxsome Therapeutics Enters into License Agreement with..
2/14/202317:30EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202316:15EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202315:46EDGARAmended Statement of Ownership (sc 13g/a)
2/07/202307:00GLOBEAxsome Therapeutics to Present at the SVB Securities Global..
2/01/202316:56EDGARAmended Statement of Ownership (sc 13g/a)
1/31/202307:00GLOBEAxsome Therapeutics to Report Fourth Quarter and Full Year..
12/09/202211:05TRMNMizuho Securities Sticks to Their Buy Rating for Axsome..
12/07/202207:00GLOBEAxsome Therapeutics Presents New Data from the EVOLVE..
12/02/202217:28EDGARAutomatic Shelf Registration Statement of Securities of..
11/30/202200:00TRMNWall Street Analysts Are Bullish on Top Healthcare Picks
11/29/202207:30TRMNAnalysts Offer Insights on Healthcare Companies: Arrowhead..
11/28/202209:15TRMNAxsome Therapeutics Rises on Promising Alzheimer’s Results
11/28/202206:35GLOBEAxsome Therapeutics Announces AXS-05 Achieves Primary..
11/23/202207:00GLOBEAxsome Therapeutics to Present at the 5th Annual Evercore..
11/22/202222:05TRMNMizuho Securities Remains a Buy on Axsome Therapeutics..
11/14/202217:53EDGARCurrent Report Filing (8-k)
11/09/202223:26TRMNSVB Securities Reaffirms Their Buy Rating on Axsome..
11/09/202207:00GLOBEAxsome Therapeutics to Present at the Guggenheim 4th Annual..
11/08/202211:35TRMNMorgan Stanley Reaffirms Their Hold Rating on Axsome..
11/07/202207:00GLOBEAxsome Therapeutics Reports Third Quarter 2022 Financial..
11/04/202201:05TRMNSVB Securities Sticks to Its Buy Rating for Axsome..
10/27/202207:00GLOBEAxsome Therapeutics to Ring the NASDAQ Stock Market Opening..
10/24/202216:02EDGARStatement of Ownership (sc 13g)
10/24/202209:35TRMNH.C. Wainwright Sticks to Their Buy Rating for Axsome..
10/21/202207:00GLOBEAxsome Therapeutics to Report Third Quarter 2022 Financial..
10/20/202207:06EDGARCurrent Report Filing (8-k)
10/20/202207:00GLOBEAxsome Therapeutics Announces Availability of AUVELITY™, the..
10/14/202206:50TRMNWall Street Analysts Are Bullish on Top Healthcare Picks
10/10/202207:00GLOBEAxsome Therapeutics Voices its Commitment to Mental Health..
10/03/202208:23TRMNAxsome Rises on Promising Sunosi Data in OSA
10/03/202207:10EDGARCurrent Report Filing (8-k)
10/03/202206:30GLOBEAxsome Therapeutics Announces Sunosi® (Solriamfetol) Meets..
10/03/202206:25TRMNH.C. Wainwright Reaffirms Their Buy Rating on Axsome..
9/29/202214:05TRMNMizuho Securities Sticks to Its Buy Rating for Axsome..
9/29/202208:16DJNAxsome to Refile AXS-07 Migraine Application in 3Q23
9/29/202207:28GLOBEAxsome Therapeutics Announces Plans to Resubmit AXS-07 NDA..